Not the I buy the blockbuster talk but just doing a little research on BioSpecifics and came across something that seemed to indicate incidence of Dupuytren's contracture is significantly higher in some European countries (which is still early on). Anyone have any thoughts on this indication or Xiaflex in other indications? Is it worth my looking into or a waste of time...better bargains out there? :-).
BSTC gets low double digit royalties and has little overhead so they would have considerable leverage in a sales ramp (presuming management doesn't have big ambitions :-))
Market Data 
Markets 
AI
